Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate

Lancet

Volumn 348, Issue 9019, 1996, Pages 27-29

  Todd, G ^a   Dunlop, K ^b   McNaboe, J ^b   Ryan, M F ^a   Carson, D ^c   Shields, M D ^c  

^a ANTRIM AREA HOSPITAL   (United Kingdom)

^b ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; HYDROCORTISONE; TETRACOSACTIDE;

ADRENAL SUPPRESSION; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CREATININE URINE LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GROWTH; GROWTH RETARDATION; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOGLYCEMIA; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0030572466     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)03339-9     Document Type: Article

References (12)

1. Russell G. Inhaled corticosteroid therapy in children: an assessment of the potential for side effects. Thorax 1994; 49: 1185-88.
2. A Six-Part Asthma Management Program. Global Strategy for Asthma Management and Prevention NHLBI/WHO Workshop. USA NIH Publication No 95-3659, 92, 1995.
3. Lundback B, Alexander M, Day J, et al. Evaluation of fluticasone propionate (500 mcg/day) administered either as dry powder via diskhaler or pressurised inhaler and compared with beclomethasone dipropionate (100 mcg/day) administered by pressurised inhaler. Resp Med 1993; 87: 609-20.
4. Ayres JG, Bateman ED, Lundbick B, Harris TAJ. HIgh dose fluticasone propionate 1 mg daily, versus fluticasone 2 mg daily, or budesonide 1.6 mg daily in patients with severe asthma. Eur Respir F 1995; 8: 579-86.
5. Harding SM The human pharmacology of fluticasone propionate. Resp Med. 84:1990;25-29.
6. Clark DJ, Grove A, Cargill RI, Lipworth P. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 1996; 51: 262-66.
7. MacKenzie CA, Weinberg EG, Tabachnik E, Taylor M, Havpan J, Crescenzi K. A placebo controlled trial of fluticasone propionate in asthmatic children. Eur F Pediatr 1993; 152: 856-60.
8. Walker JM, Hughes IA. Tests and normal values in paediatric endocrinology. In: Brook CGD, ed. Clinical Paediatric Endocrinology. Blackwell Science, 1995: 786-87.
9. Johnston DI. Endocrinology. In: Addy DP, ed. Investigations in paediatrics. WB Saunders, 1994: 52-53.
10. Wong J, Black P Acute adrenal insufficiency associated with high dose inhaled steroids. BMF. 304:1992;1414.
11. Grahnen A, Ling-Andersson A, Brundin RM, Eckernas SA. Suppressive effects of therapeutic doses of fluticasone propionate on the HPA axis in healthy volunteers. Thorax 1995; 50: 105-10.
12. Dogterom P, Oosterhuis B, Ebels JT, Jonkman JH Inhaled fluticasone propionate induces greater cortisol suppression compared to budesonide. A dose response study using pressurised metered dose inhalers (PMDI's). Eur Respir F. 8:1995;303.